We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Low-dose 0.01% atropine eye drops safely slowed myopia ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to ...

Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study. The global prevalence of myopia was estimated to be 30% to 34% in 2020 and ...

Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with those using placebo or 0.01% atropine, though they had higher rates of ...

Waldwick, New Jersey / Syndication Cloud / January 23, 2026 / A2Z Eyecare P.C Key Takeaways Myopia and astigmatism frequently develop together in children, making coordinated care important. Myopia ...

Child eye test and eye exam. Little girl having eye check-up, with phoropter. Doctor performs eye test for child. This story is part of a series on the current progression in Regenerative Medicine.

Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050. Ophthalmologists are gravely concerned that these ...

Share on Pinterest Experts say the incidence of nearsightedness in children is rising. Catherine Falls Commercial/Getty Images Experts say that developing nearsightedness as a child might be an ...

A nightly use of 0.05% atropine eyedrops resulted in a lower incidence of myopia compared with placebo. Reduced incidence of myopia and myopic shift after 2 years of follow-up was seen in patients who ...

Myopia affects roughly one third of the population worldwide ― a figure that is projected to reach 50% by 2050. Low-dose atropine, which helps curb the condition, currently is available in the United ...